Last Update Time:
19-Mar-2025 15:48:56
ISIN:
INE098F01031
Sector:
Healthcare
Symbol:
AMRUTANJAN
Amrutanjan Health Care Limited
₹613.00
₹8.80
(1.46%)
▲
Prev. Close
₹604.20
Open
₹604.80
Close
₹0.00
Range
₹582.35 - ₹643.65
High
₹614.00
Low
₹604.80
Ind. Close
₹0.00
VWAP
₹610.93
The current stock price of Amrutanjan Health Care Limited is ₹613.00, with a target price range between ₹582.35 and ₹643.65. The stock has experienced a price change of ₹8.80 (1.46%), reflecting recent market volatility.
Today's opening price was ₹604.80, while the previous close stood at ₹604.20.
The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.
For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.
Amrutanjan Health Care Limited Price Chart
Amrutanjan Health Care Limited Pre Open Market Overview: 19-Mar-2025
Key Metrics:
- IEP (Indicative Equilibrium Price): 604.8
- Previous Close Price: 604.2
- Change: 0.60%
- Total Traded Volume: 49
- Total Buy Quantity: 1,865
- Total Sell Quantity: 2,662
| Price | Buy Qty | Sell Qty |
|---|---|---|
| 592.00 | 70.00 | 0.00 |
| 595.00 | 43.00 | 0.00 |
| 595.55 | 25.00 | 0.00 |
| 596.00 | 50.00 | 0.00 |
| 604.80 | 0.00 | 0.00 |
| 606.75 | 19.00 | 0.00 |
| 608.00 | 0.00 | 26.00 |
| 608.90 | 0.00 | 10.00 |
| 609.00 | 0.00 | 14.00 |
| 609.05 | 0.00 | 14.00 |
| 609.15 | 0.00 | 14.00 |
ATO Data:
- Buy Quantity (ATO): 0
- Sell Quantity (ATO): 0
Order Book
| Bid | Qty | Ask | Qty |
|---|---|---|---|
| 612.10 | 90 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
| 0.00 | 0 | 0.00 | 0 |
Total Buy Quantity: 1865
Total Sell Quantity: 2662
Shareholding Patterns of Amrutanjan Health Care Limited
Key Trade Statistics of Amrutanjan Health Care Limited
| Trade Information | Details |
|---|---|
| Traded Volume (Lakhs) | 0.25 |
| Traded Value (₹ Cr.) | 1.51 |
| Total Market Cap (₹ Cr.) | 1,772.22 |
| Free Float Market Cap (₹ Cr.) | 921.43 |
| Impact cost | 0.2 |
| Quantity Traded | 20,091.00 |
| Deliverable Quantity | 16,910.00 |
| % of Quantity to Traded | 84.17 |
| Security VaR | 12.67 |
| Index VaR | N/A |
| VaR Margin | 12.67 |
| Extreme Loss Rate | 3.5 |
| Adhoc Margin | N/A |
| Applicable Margin Rate | 16.17 |
| Face Value | 1 |
Key Price Statistics of Amrutanjan Health Care Limited
The 52-week high for Amrutanjan Health Care Limited was ₹862.60, recorded on 28-Aug-2024. On the other hand, the 52-week low stands at ₹559.95, with the lowest value recorded on 03-Mar-2025.
The upper band for trading is ₹725.00, and the lower band is ₹483.40. The price band is 20%.
The stock's daily volatility stands at 1.99, while the annualized volatility is 38.02. The tick size for trading is ₹0.05.
| Price Information | Details |
|---|---|
| 52 Week High (28-Aug-2024) | 862.60 |
| 52 Week Low (03-Mar-2025) | 559.95 |
| Upper Band | 725.00 |
| Lower Band | 483.40 |
| Price Band (%) | 20 |
| Daily Volatility | 1.99 |
| Annualised Volatility | 38.02 |
| Tick Size | 0.05 |
Key Securities Statistics of Amrutanjan Health Care Limited
| Securities Information | Details |
|---|---|
| Status | Listed |
| Trading Status | Active |
| Date of Listing | 02-Jan-2015 |
| Adjusted P/E | 35.42 |
| Symbol P/E | 35.42 |
| Index | NA |
| Macro-Economic Sector | Healthcare |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Biotechnology |
| Basic Industry | Pharmaceuticals |
Security Status of Amrutanjan Health Care Limited
| Title | Details |
|---|---|
| Board Status | Main |
| Trading Segment | Normal Market |
| Session No. | - |
| Class of Shares | Equity |
| SDD Compliance | - |
| Name of Compliance Officer | - |
Announcements of Amrutanjan Health Care Limited
| Subject | Date |
|---|---|
| Action(s) initiated or orders passed | 03-Mar-2025 |
| Action(s) initiated or orders passed | 03-Mar-2025 |
| Investor Presentation | 14-Feb-2025 |
| Copy of Newspaper Publication | 14-Feb-2025 |
| Record Date | 12-Feb-2025 |
| Outcome of Board Meeting-XBRL | 12-Feb-2025 |
| Integrated Filing- Financial | 12-Feb-2025 |
| Financial Result Updates | 12-Feb-2025 |
Corporate Actions of Amrutanjan Health Care Limited
| Face Value | Purpose | Ex-Date |
|---|---|---|
| 1 | Interim Dividend - Re 1 Per Share | 18-Feb-2025 |
| 1 | Interim Dividend - Re 1 Per Share | 22-Nov-2024 |
| 1 | Dividend - Rs 2.60 Per Share | 13-Sep-2024 |
| 1 | Annual General Meeting | 13-Sep-2024 |
| 1 | Interim Dividend - Re 1 Per Share | 20-Feb-2024 |
| 1 | Interim Dividend - Rs 1 Per Share | 23-Nov-2023 |
| 1 | Annual General Meeting/Dividend - Rs 2.60 Per Share | 14-Sep-2023 |
| 1 | Buy Back | 13-Jul-2023 |
| 1 | Interim Dividend - Re 1 Per Share | 24-Feb-2023 |
| 1 | Interim Dividend - Re 1 Per Share | 14-Nov-2022 |
| 1 | Annual General Meeting/Dividend - Rs 2.60 Per Share | 14-Sep-2022 |
| 1 | Interim Dividend - Re 1 Per Share | 18-Feb-2022 |
| 1 | Interim Dividend - Re 1 Per Share | 16-Nov-2021 |
| 1 | Annual General Meeting/Dividend - Rs 2.60 Per Share | 15-Sep-2021 |
| 1 | Interim Dividend - Rs 0.80 Per Share | 17-Feb-2021 |
| 1 | Interim Dividend - Rs 0.80 Per Share | 19-Nov-2020 |
| 1 | Annual General Meeting | 15-Sep-2020 |
| 1 | Interim Dividend - Re 1.55 Per Share | 18-Feb-2020 |
| 1 | Interim Dividend - Rs 0.55 Per Share | 15-Nov-2019 |
| 1 | Dividend - Rs 1.05 Per Share | 17-Sep-2019 |
Board Meetings of Amrutanjan Health Care Limited
Financial Results of Amrutanjan Health Care Limited
Company Directory of Amrutanjan Health Care Limited
| Web Address | Office | Address | City |
|---|---|---|---|
| N/A | Registered Office | No 103, (Old 42-45), Luz Church Road, Mylapore |
CHENNAI |
| N/A | Transfer Agent | Cameo Corporate Services Ltd. Subramanian Building No. 1, Club House Road |
CHENNAI |
Insider Trading of Amrutanjan Health Care Limited
| Reg. Clause | Acq./Disp. | Sec. Value | Txn Type |
|---|---|---|---|
| 7(2) | NAGESWARAMMA PRIVATE TRUST | 247264232 | Sell |
| 7(2) | NAGESWARAMMA PRIVATE TRUST | 617115843 | Sell |
| 7(2) | RAMAA PRABHAKAR ARIKIREVULARA | 0 | Buy |
| 7(2) | Amulya Kamakshi Priya Arikirevula | 0 | Buy |
| 7(2) | S SAMBHU PRASAD EXECUTOR TO THE ESTATE OF S RAMAYAMMA | 0 | Sell |
| 7(2) | S SAMBHUPRASAD | 0 | Buy |
| 7(2) | S SAMBHU PRASAD EXECUTOR TO THE ESTATE OF S RAMAYAMMA | 0 | Buy |
| 7(2) | S RAMAYAMMA | 0 | Sell |
| 7(2) | PASUMARTHI SATHYANARAYANA MURTHI | 0 | Sell |
| 7(2) | NAGESWARAMMA PRIVATE TRUST | 0 | Buy |
| 7(2) | PASUMARTHI SATHYANARAYANA MURTHI | 0 | Sell |
| 7(2) | AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST | 7688625 | Buy |
| 7(2) | AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST | 39520 | Buy |
| 7(2) | AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST | 7822000 | Buy |
| 7(2) | AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST | 1578500 | Buy |
| 7(2) | AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST | 39273 | Buy |
| 7(2) | G Raghavan | 1228830 | Buy |
| 7(2) | G Raghavan | 408350 | Buy |
| 7(2) | AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST | 2628000 | Buy |
| 7(2) | AMRUTANJAN HEALTH CARE LIMITED ESOP TRUST | 2196250 | Buy |
Annual Reports of Amrutanjan Health Care Limited
Investor Complaints of Amrutanjan Health Care Limited
Event Calendar of Amrutanjan Health Care Limited
| Purpose | Details |
|---|---|
| Results/Dividend | To consider the Audited Financial Results of the Company for the year ended 31st March 2010 and also to recommend final dividend on the equity shares of the Company, for the financial year 2009-10. (Source MSE) |
| Results/Others | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company to be held on 14th July 2010 to consider and take on record the audited financial results of the Company, as also recommendation of final dividend for the year ended 31st March 2010. The Company has now informed that the Board of Directors of the Company scheduled to be held on 14th July 2010 will additionally consider the update on the buy back offer made by the Company and restructuring possiblilites for the Company. (Source MSE) |
| Others | To consider new business proposals. (Source MSE) |
| Results / Buyback | The Company had earlier informed the Exchange regarding meeting of Board of Directors of the Company to be held on 3rd May 2011 to consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the fourth quarter ended 31st March 2011. The Company has now informed the Exchange that the Board of Directors of the Company at their meeting to be held on 3rd May 2011 will also consider and approve, inter-alia, the proposal for buy-back of equity shares of the Company under Section 77A of the Companies Act, 1956 and SEBI (Buy-Back of Securities) Regulations, 1998, through a method to be decided by the Board. (Source MSE) |
| Others | The Company had earlier informed the Exchange regarding a meeting of Board of Directors of the Company to be held on 8th August 2011 to consider and take on record, inter-alia, the Un-audited Financial Results of the Company for the quarter ended 30th June 2011. The Company has now informed the Exchange that the Board of Directors of the Company, at its meeting, to be held on 8th August 2011 may consider and declare a Final Dividend for the financial year 2010-11 (Purpose revised). (Source MSE) |
| Results/Dividend | Inter-alia to consider the following: (1) Un-audited Financial Results for the quarter ended 31st December, 2011 and (2) Declaration of Interim Dividend for the nine months ended 31st December 2011. (Source MSE) |
| Results/Others | The meeting of Board of Directors of the Company scheduled to be held on 13th February, 2012 shall, in addition to un-audited results for the quarter ended 31st December 2011.also consider amalgamation of Wholly Owned Subsidiary M/s. Siva's Soft Drinks Private Limited with the Company. (Source MSE) |
| Results/Dividend | The Company had earlier informed the Exchnage that the Board Meeting to be held on 30th May 2012, inter-alia, will consider the Audited Financial Results for the quarter/year ended 31st March 2012. The Company has now informed that the Board of Directors may also consider recommendation of Final Dividend for the financial year ended 31st March 2012. (Source MSE) |
| Board Meeting Postponed | Due to unforeseen circumstances the meeting of the Board of Directors of the Company scheduled to be held on 7th November 2012, to consider inter-alia the Un-audited Financial Results of the Company for the quarter / Half year ended 30th September 2012, along with the statement of assets and liabilities for the half year ended 30th September 2012, has now been fixed for 9th November 2012. (Source MSE) |
| Results/Dividend | Inter-alia to consider the following: (1) Un-audited Financial Results of the Company for the quarter / nine months ended 31st December 2012; and 2. Interim Dividend. (Source MSE) |
| Results/Dividend | Inter-alia to consider the Audited Financial Results of the Company for the quarter/year ended 31st March 2013; and to consider recommendation of Final Dividend for the Financial year ended 31st March 2013. (Source MSE) |
| Results | To consider inter-alia the Un-audited Financial Results of the Company for the quarter ended 30th June 2013. (Source MSE) |
| Results | To Consider inter-alia the Unaudited Financial Results for the Quarter / Half Year ended on 30th September 2013 along with the statement of Assets and Liabilities for the Quarter / Half Year ended on 30th September 2013. (Source MSE) |
| Results/Dividend | Inter-alia to consider the following:- (1). Un-Audited Financial Results for the quarter / Nine month ended on 31st December 2013. (2) Interim Dividend. (Source MSE) |
| Results/Dividend | Inter alia to consider the Audited Financial Results for the Quarter / Year ended on 31st March 2014 along with Statement of Assets and Liabilities for the year ended on 31st March 2014 and to consider recommendation of Final Dividend for the Financial Year ended on 31st March 2014. (Source MSE) |
| Results | To consider inter-alia the un-audited financial results for the quarter ended 30th June 2014. (Source MSE) |
| Results | To consider inter-alia the un-audited financial results for the quarter / half yeard ended 30th September 2014, along with the statement of assets and liabilities for the quarter / half year ended 30th September 2014 (Source MSE) |
| Results/Dividend | Inter-alia to consider the following 1. Un-audited financial results for the quarter / nine months ended December 31, 2014. 2. Interim Dividend. |
| Results/Dividend | Inter alia to consider the Audited Financial Results for the quarter/year ended March 31, 2015 along with the statement of assets and liabilities for the year ended March 31, 2015 and to consider recommendation of Final Dividend for the Financial year ended March 31, 2015. |
| Results | To consider inter-alia the un-audited financial results for the quarter ended June 30, 2015. |
| Results | To consider inter-alia the unaudited Financial Results for the Quarter / Half year ended September 30, 2015 along with the statement of assets and liabilities for the Quarter / Half Year ended September 30, 2015. |
| Results/Dividend | to consider and approve the following:1. un-audited Standalone Financial Results for the quarter and nine months ending December 31, 20152. Declaration and payment of Interim Dividend for the Financial year 2015-16 on Equity shares. |
| Dividend | to consider and approve, inter-alia, the following,declaration and payment of 2nd interim dividend for the financial year 2015-16 on Equity shares. |
| Results | To consider and approve, inter-alia, the following:Audited Standalone Financials for the quarter and year ending March 31, 2016 and audited Consolidated Financials for the year ending March 31, 2016. |
| Results/Others | To consider and approve, inter alia, the following:1. Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter ending June 30, 2016.2. Merger of the Wholly-owned Subsidiary, M/s. Amrutanjan Pharmaessence Private Limited with M/s. Amrutanjan Health Care Limiited. |
| Results | To consider and approve , inter alia :Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter/half yearly ending September 30, 2016. |
| Results/Dividend | The Company had informed the Exchange regarding a meeting of the Board of Directors of the Company schedule to be held November 10, 2016, To consider and approve , inter alia :Unaudited Standalone Financial Results together with Limited Review Report of the Auditors for the quarter/half yearly ending September 30, 2016.The Company has now informed the Exchange will also consider Declaration of Interim Dividends on quarterly basis & approval of 1st Interim Dividend for the year 2016-17(Purpose Revised). |
| Results/Dividend | To consider and approve, inter-alia, the following: 1. Un-audited Standalone Financial Results along with the Limited Review Report for the quarter and nine months ended December 31, 2016. 2. Declaration of 2nd interim dividend for the financial year 2016-17. |
| Results/Dividend | To consider and approve, inter-alia, the following: 1. Audited Standalone and Consolidated Financial Results along with the Report of the Statutory Auditor for the Quarter and Year ended March 31, 2017. 2. Declaration of Final Dividend for the financial year 2016-17; if any . |
| Results/Others | To consider and approve, inter-alia, the a) Un-audited Financial Results along with the Limited Review Report for the quarter ended June 30, 2017. b) Fix record date for the payment of dividend subject to the approval of the shareholders. |
| Results/Dividend | To consider and approve, inter-alia, the a) Un-audited Financial Results along with the Limited Review Report for the quarter and half year ended September 30, 2017. b) Declaration of 1st interim dividend for the financial year 2017-18 . |
| Results/Dividend/Stock-split | to consider and approve, inter alia to 1) Sub-division of equity shares of face value of Rs. 2/-each. 2) Un-audited Financial Results along with the limited review report for the quarter and nine months ended December 31, 2017. 3) Declaration of Second Interim Dividend for the financial year 2017-18. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2018 and dividend |
| Financial Results/Dividend | To consider and approve, inter alia, the 1) Audited Financial Results along with the Audit Report of the Statutory Auditor for the Quarter and year ended March 31, 2018. 2)Declaration of Final Dividend for the financial year 2017-18 if any. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2018 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2018 and declare First Interim dividend for the Financial Year 2018-19 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2018 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2019 and dividend |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2019 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2019 and to declare first interim dividend for the financial year 2019-20 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2019 and to declare second interim dividend for FY 19-20 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2020 |
| Fund Raising | Pursuant to the SEBI LODR regulations and our earlier communication under reference, we wish to inform that at the meeting of Board of Directors scheduled to be held on Thursday,13th August 2020, the Board shall inter-alia, also consider for approval the proposal to grant Employee Stock Option Scheme (also known as AHCL ESOP 2020).If the proposal is approved, the same shall be recommended for approval of members of the Company. |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2020 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2020 and to declare first interim dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2020 and declare second interim dividend for 2020-21 |
| Financial Results | To consider and approve the financial results for the period ended March 31, 2021 |
| Dividend | To consider final dividend for 2020-21 |
| Other business matters | To consider and approve appointment of Additional Director |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2021 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2021 and to declare interim dividend |
| Dividend | To consider and declare Second Interim Dividend for the year 2021-22 |
| Financial Results | To consider and approve the financial results for the period ended December 31, 2021 |
| Financial results | Amrutanjan Health Care Limited has informed the Exchange about Board Meeting to be held on 12-Aug-2022 to consider financial statements for the period ended June 2022 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2022 and dividend |
| Financial Results/Dividend | AMRUTANJAN : 30-May-2023 : The Company has informed the Exchange that a Board meeting to be held on May 27, 2023 has been re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on May 30, 2023, To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended March 31, 2023 and dividend |
| Buyback | To consider buyback for equity shares |
| Financial Results | To consider and approve the financial results for the period ended Jun 30, 2023 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2023 and Declaration of 1st Interim Dividend for the financial year 2023-24. |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2023 and dividend |
| Financial Results/Dividend | To consider and approve the audited financial results for the period ended March 31, 2024 and recommendation of final dividend |
| Financial Results | To consider and approve the Un-Audited financial results for the period ended Jun 30, 2024 |
| Financial Results/Dividend | To consider and approve the financial results for the period ended September 30, 2024 and dividend |
| Financial Results/Dividend | To consider and approve the financial results for the period ended December 31, 2024 and dividend |
Share Transfers of Amrutanjan Health Care Limited
Voting Results of Amrutanjan Health Care Limited
| Date of Mtg. | Mtg. Type | Resolution |
|---|---|---|
| 23-SEP-2024 | AGM | To adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2024, together with the reports of the Board of Directors and Auditors thereon |
| 23-SEP-2024 | AGM | To approve the remuneration of M/s. Geeyes & Co., Cost Auditors for the financial year 2024-25 |
| 23-SEP-2024 | AGM | Appointment of Mr. V NAGARAJ (DIN: 00190903) as Non-executive Independent Director |
| 23-SEP-2024 | AGM | Re-appoint Ms. Ramaa Prabhakar Arikirevula (DIN:09465903) Non-Executive Non-Independent Director |
| 23-SEP-2024 | AGM | To declare a Final Dividend of ￂ2.60/- per Equity Share of ￂ1/- each for the year ended March 31, 2024 |
| 27-DEC-2023 | Postal Ballot | As given in the Report of Scrutinizer dated 28-12-2023 and Notice of Postal Ballot dated 27-11-2023 |
| 21-SEP-2023 | AGM | To adopt the Audited Financial Statements of the Company for the financial year ended March 31, 2023, together with the reports of the Board of Directors and Auditors thereon |
| 21-SEP-2023 | AGM | To approve the remuneration of M/s. Geeyes & Co., Cost Auditors for the financial year 2023-24 |
| 21-SEP-2023 | AGM | To approve the appointment of Mr. G. Raghavan (DIN: 0820000) who is retiring as Non-Executive Independent Director of the Company as Non-Executive Non-Independent which appointment shall be subject to retirement by rotation. |
| 21-SEP-2023 | AGM | To approve the appointment of Ms. Ramaa Prabhakar Arikirevula (DIN 09465903) by the Board to fill the casual vacancy caused due to the death of Dr. Pasumarthi S.N. Murthi (DIN 00051303) to hold the office from June 30, 2023 up to the Conclusion of the 86th Annual General Meeting and to approve her appointment as non-executive non-independent director which appointment shall be subject to retirement by rotation. |
| 21-SEP-2023 | AGM | To declare a Final Dividend of ￂ2.60/- per Equity Share of ￂ1/- each for the year ended March 31, 2023 |
| 22-SEP-2022 | AGM | TO CONSIDER AND ADOPT THE AUDITED FINANCIAL STATEMENTS OF THE COMPANY FOR THE FINANCIAL YEAR ENDED MARCH 31, 2022 TOGETHER WITH THE REPORTS OF THE BOARD OF DIRECTORS AND AUDITORS THEREON |
| 22-SEP-2022 | AGM | TO RATIFY REMUNERATION PAYABLE TO THE COST AUDITOR MR. G. THANGARAJ (REG. NO. 100464) FOR FINANCIAL YEAR 2022-23 |
| 22-SEP-2022 | AGM | TO APPOINT MS. MEENALOCHANI RAGHUNATHAN (DIN: 07145001) AS A NON-EXECUTIVE INDEPENDENT DIRECTOR |
| 22-SEP-2022 | AGM | TO APPOINT DR. PASUMARTHI S.N. MURTHI (DIN 00051303), NON-EXECUTIVE DIRECTOR OF THE COMPANY, WHO RETIRES BY ROTATION AND BEING ELIGIBLE OFFERS HIMSELF FOR RE-APPOINTMENT |
| 22-SEP-2022 | AGM | TO APPROVE RE-APPOINTMENT OF M/s. B S R & CO. LLP, CHARTERED ACCOUNTANTS, AS STATUTORY AUDITORS OF THE COMPANY AND FIX THEIR REMUNERATION: |
| 22-SEP-2022 | AGM | TO DECLARE A FINAL DIVIDEND OF RS 2.60/- PER EQUITY SHARE OF FACE VALUE OF RE. 1/- EACH FOR THE YEAR ENDED MARCH 31, 2022. |
| 23-SEP-2021 | AGM | Adoption of the Audited Financial Statements of the Company for the financial year ended March 31 2021 together with the reports of the Board of Directors and Auditors thereon |
| 23-SEP-2021 | AGM | Re- Appointment of Dr. Pasumarthi S N Murthi (DIN 00051303) who retires by rotation, as Non-Executive Director |
| 23-SEP-2021 | AGM | Declaration of Final Dividend of Rs. 2.60/- per Equity Share of face value of Re. 1/- each for the year ended March 31, 2021 |
FAQs on Amrutanjan Health Care Limited
Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.